DeepMed Research

University of Kansas Medical Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1906-01-01

Employees: 5K

Market Cap: -

Website: https://www.kumc.edu

Clinical Trials

Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis

Phase 2

Completed

Conditions: ALS

Interventions: Drug: Ranolazine 500 MG
Drug: Ranolazine 1000 MG

First Posted Date: 2018-03-21

Last Posted Date: 2024-12-09

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 14

Registration Number: NCT03472950

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Benefits of Mild Body Exercises in Parkinson's Disease

Not Applicable

Conditions: Parkinson Disease

Interventions: Behavioral: Qigong exercise
Behavioral: Mild body exercise

First Posted Date: 2018-03-13

Last Posted Date: 2022-01-21

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 65

Registration Number: NCT03463330

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Intensive Preoperative Ostomy Education for the Radical Cystectomy Patient

Not Applicable

Completed

Conditions: Stoma Ileostomy

Interventions: Behavioral: Stoma Boot Camp
Other: Standard of Care

First Posted Date: 2018-03-12

Last Posted Date: 2020-09-10

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 65

Registration Number: NCT03462667

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Omission of Radiation in Patients With Her-2 Positive Breast Cancer

Not Applicable

Active, not recruiting

Conditions: HER2-positive Breast Cancer

Interventions: Radiation: Omission of Radiation

First Posted Date: 2018-03-09

Last Posted Date: 2025-03-27

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 12

Registration Number: NCT03460067

Locations: 🇺🇸
University of Kansas Medical Center/ Cancer Center, Kansas City, Kansas, United States

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

Recruiting

Conditions: Facioscapulohumeral Muscular Dystrophy

Interventions: Diagnostic Test: FSHD-specific functional rating scale
Device: Electrical Impedance Myography

First Posted Date: 2018-03-08

Last Posted Date: 2025-04-23

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 320

Registration Number: NCT03458832

Locations: 🇺🇸
University of California Los Angeles, Los Angeles, California, United States
🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States

and more 11 locations

Central Nervous System Amplification in Lumbar Failed Back Surgery Syndrome

Completed

Conditions: Chronic Pain

First Posted Date: 2018-02-23

Last Posted Date: 2024-02-09

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 158

Registration Number: NCT03444168

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

The LATCHING Pilot Project

Not Applicable

Completed

Conditions: Breastfeeding

Interventions: Other: Usual prenatal care
Behavioral: Behavior Lifestyle Intervention

First Posted Date: 2018-02-22

Last Posted Date: 2019-05-30

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 46

Registration Number: NCT03442517

Locations: 🇺🇸
Priority Care Pediatrics, LLC, Kansas City, Missouri, United States
🇺🇸
Northland Obstetrics & Gynecology, Inc., Liberty, Missouri, United States
🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

The Altered Immune Response to Exercise in Patients With Fibromyalgia Before and After a Mind-body Intervention

Not Applicable

Conditions: Fibromyalgia

Interventions: Other: Mind-body exercise
Other: Light mobility exercises

First Posted Date: 2018-02-22

Last Posted Date: 2019-01-04

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 40

Registration Number: NCT03441997

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240

Early Phase 1

Active, not recruiting

Conditions: Cystic Fibrosis

Interventions: Drug: Losartan

First Posted Date: 2018-02-19

Last Posted Date: 2024-12-06

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 16

Registration Number: NCT03435939

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Piloting At-birth Point of Care HIV Testing Strategies in Kenya

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Behavioral: Alere q HIV-1/2 Detect for point of care infant testing
Behavioral: GeneXpert HIV-1 Qual for point of care infant testing
Behavioral: HIV DNA PCR testing (Standard of Care)

First Posted Date: 2018-02-19

Last Posted Date: 2020-07-14

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 1999

Registration Number: NCT03435887

Locations: 🇰🇪
Kombewa District Hospital, Kombewa, Kenya
🇰🇪
Kisumu County Hospital, Kisumu, Kenya
🇰🇪
Tudor Sub-County Hospital, Mombasa, Kenya

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy